In an attempt to develop an efficient chemotherapeutic agent targeted at ma
lignant cells that express receptors to gonadotropin releasing hormone (GnR
H) we coupled [D-Lys(6)]GnRH covalently to an emodin derivative, i.e. emodi
c acid (Emo) to yield [D-Lys(6)(Emo)]GnRH. Emodin is a naturally occurring
anthraquinone which is widely used as a laxative and has other versatile bi
ological activities. Physico-chemical studies employing electron paramagnet
ic resonance and electrochemistry of the conjugate as well as the (Emo) moi
ety showed that these compounds could be easily reduced either chemically,
photochemically or enzymatically to their corresponding semiquinones. In th
e presence of oxygen the semiquinones generated reactive oxygen species (RO
S), mainly superoxide and hydroxyl radicals, which were detected by the spi
n trapping method. Moreover, upon irradiation with visible light these comp
ounds produced ROS and a highly reactive excited triplet state of Emo, whic
h by itself may cause the oxidation of certain electron acceptors such as a
mino acids and bases of nucleic acids. Thus, [D-Lys(6)]GnRH-photosensitizer
conjugates may be potentially used for targeted photodynamic chemotherapy
aimed at treating cancer cells that carry GnRH receptors. These conjugates
may also induce cytotoxicity in the dark similar to common conventional che
motherapeutic agents. The peptidic moiety, [D-Lys(6)]GnRH, was found to be
stable toward highly reactive ROS generated either from enzymatic reduction
or upon photoirradiation. The physico-chemical properties of Emo were only
marginally influenced by the peptidic [D-Lys(6)]GnRH carrier.